Abrdn Life Sciences Investors (HQL) Total Return Calculator
$10,000 since Dec 2007, with and without reinvesting · data through Oct 2026
$10,000 invested in Abrdn Life Sciences Investors (HQL) ten years ago, at the end of Oct 2016, was worth $28,723 at the end of Oct 2026 with every dividend reinvested: 11.1% a year, against $41,633 in the S&P 500. Since Dec 2007, $10,000 became $75,574 reinvested (11.3% a year), or $35,490 taking the dividends as cash, $21,573 of it paid out along the way.
HQL became
$75,574
S&P 500: $72,756
Return a year
11.3%
S&P 500: 11.1%
Payouts reinvested
$55,783
bought more shares
Worst drop
-37.3%
S&P 500: -48.2%
$10,000, Dec 2007 to Oct 2026
Payouts reinvested · S&P 500 reinvested
| Year | HQL total return | Paid out | S&P 500 |
|---|---|---|---|
| 2026 (part) | +20.5% | $6,704 | +11.7% |
| 2025 | +45.4% | $6,497 | +17.7% |
| 2024 | +11.2% | $5,778 | +24.9% |
| 2023 | +4.3% | $3,501 | +26.2% |
| 2022 | −19.2% | $3,393 | −18.2% |
| 2021 | +5.5% | $3,881 | +28.7% |
| 2020 | +23.7% | $3,292 | +18.3% |
| 2019 | +25.4% | $2,683 | +31.2% |
| 2018 | −16.1% | $2,949 | −4.6% |
| 2017 | +23.0% | $2,093 | +21.7% |
| 2016 | −19.6% | $3,059 | +12.0% |
| 2015 | +5.8% | $3,827 | +1.2% |
| 2014 | +31.2% | $2,194 | +13.5% |
| 2013 | +52.4% | $1,667 | +32.3% |
| 2012 | +37.2% | $1,307 | +16.0% |
| 2011 | +16.3% | $1,046 | +1.9% |
| 2010 | +20.7% | $551 | +15.1% |
| 2009 | +14.7% | $424 | +26.4% |
| 2008 | −27.5% | $936 | −36.8% |
"Paid out" is what your holding received that year. Month-end prices; no costs or taxes.
Key facts: HQL total return
Data as of · Source: SmarterDividends data
- $10,000 invested in Abrdn Life Sciences Investors (HQL) at the end of Dec 2007, with dividends reinvested, was worth $75,574 at the end of Oct 2026: 11.3% a year, against $72,756 (11.1% a year) in the S&P 500.
- Over the 10 years to Oct 2026, HQL turned $10,000 into $28,723 with dividends reinvested, 11.1% a year.
- Over the 5 years to Oct 2026, HQL returned 8.7% a year with dividends reinvested (S&P 500: 12.0%).
- Taking HQL's dividends as cash instead of reinvesting them, the same $10,000 ended at $35,490, including $21,573 of cash received; reinvesting added $40,084.
- HQL's best calendar year in that time was 2013 (52.4%) and its worst 2008 (-27.5%), with dividends reinvested.
Cite this page
SmarterDividends, "Abrdn Life Sciences Investors (HQL) Total Return Calculator," updated Nov 9, 2026, https://smarterdividends.com/stocks/HQL/total-return
HQL total return questions
If I invested $10,000 in HQL 10 years ago, how much would I have?
About $28,723 at the end of Oct 2026, with every dividend reinvested: 11.1% a year. Taking them as cash, you'd have shares worth $11,009 or so plus the cash you received. The same $10,000 in the S&P 500 became $41,633.
What is HQL's total return since Dec 2007?
656% in total, or 11.3% a year, through Oct 2026 with dividends reinvested. The share price alone rose 39%.
How much of HQL's return came from dividends?
About 84% of its yearly return since Dec 2007. Reinvesting them, rather than taking cash, left you $40,084 better off on a $10,000 start.
What was HQL's worst year?
2008, at -27.5% with dividends reinvested (S&P 500: -36.8%). Its deepest fall from a peak, on month-end values, was -37.3%.
How is total return calculated here?
From month-end prices: the adjusted price counts every dividend reinvested in the month it was paid; the plain price doesn't. The S&P 500 is SPY with its dividends reinvested. No trading costs or taxes.